Royal Bank Of Canada Vapotherm Inc Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.4 - $0.67 $2,245 - $3,761	5,614 New	5,614 $2,000
Q2 2022 Aug 15, 2022	BUY	$2.52 - $14.42 $1,562 - $8,940	620 Added 12.3%	5,662 $14,000
Q1 2022 May 16, 2022	SELL	$12.69 - $20.72 $37,879 - $61,849	-2,985 Reduced 37.19%	5,042 $70,000
Q4 2021 Feb 14, 2022	BUY	$19.7 - $23.71 $38,336 - $46,139	1,946 Added 32.0%	8,027 $167,000
Q3 2021 Nov 15, 2021	BUY	$21.32 - $29.36 $37,288 - $51,350	1,749 Added 40.37%	6,081 $136,000
Q2 2021 Aug 16, 2021	BUY	$17.01 - $24.14 $73,687 - $104,574	4,332 New	4,332 $103,000

1.29M

Ticker VAPO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,697,200
Market Cap $57.9M
Description
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.